1. Home
  2. OMH vs BCTX Comparison

OMH vs BCTX Comparison

Compare OMH & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

N/A

Current Price

$1.24

Market Cap

32.6M

Sector

Finance

ML Signal

N/A

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$3.97

Market Cap

28.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMH
BCTX
Founded
2015
2014
Country
Singapore
Canada
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.6M
28.8M
IPO Year
2022
2025

Fundamental Metrics

Financial Performance
Metric
OMH
BCTX
Price
$1.24
$3.97
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
32.3K
176.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$28.40
N/A
Revenue Next Year
$23.07
$380.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.61
52 Week High
$4.33
$14.68

Technical Indicators

Market Signals
Indicator
OMH
BCTX
Relative Strength Index (RSI) 44.13 41.58
Support Level $1.04 $3.60
Resistance Level $1.37 $4.42
Average True Range (ATR) 0.10 0.27
MACD -0.03 0.12
Stochastic Oscillator 11.43 56.06

Price Performance

Historical Comparison
OMH
BCTX

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: